FDA Import Refusal BUP-1763496-8/10002/1 — NerPharMa S.r.l.
The FDA refused shipment BUP-1763496-8/10002/1 from NerPharMa S.r.l. (Italy) on October 29, 2025. The refused product falls under Drugs and Biologics — DASATINIB. Cited charges: 118,75 This firm has 2 other import refusals on record.
Refusal Details
- Date
- October 29, 2025
- Country
- Italy
- Product Category
- Drugs and Biologics
- Product Code
- 62ZIY13 DASATINIB
- Charges
- 118,75